Ascertaining an appropriate diagnostic algorithm using EGFR mutation-specific antibodies to detect EGFR status in non-small-cell lung cancer. - Wikidata - awgldk - TriplyDB

Ascertaining an appropriate diagnostic algorithm using EGFR mutation-specific antibodies to detect EGFR status in non-small-cell lung cancer.

Ascertaining an appropriate diagnostic algorithm using EGFR mutation-specific antibodies to detect EGFR status in non-small-cell lung cancer.

http://www.wikidata.org/entity/Q34639632

about

Immunohistochemical detections of EGFR mutations in NSCLC Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma Efficacy of bronchoscopic biopsy for the detection of epidermal growth factor receptor mutations and anaplastic lymphoma kinase gene rearrangement in lung adenocarcinoma.The utility of immunohistochemistry for providing genetic information on tumors.Prognostic and predictive biomarkers in lung cancer. A review.EGFR analysis: current evidence and future directions.Current and future molecular diagnostics in non-small-cell lung cancer.Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study.Detection of epidermal growth factor receptor mutations in lung adenocarcinoma cytological specimens by immunocytochemistry.[Immunohistochemical detections of EGFR status in NSCLC].Diamond: immunohistochemistry versus sequencing in EGFR analysis of lung adenocarcinomas.[Influence of Immunohistochemistry Scoring Criteria in Detecting EGFR Mutations].

P2860

Q26866152-C5789CAE-D45C-4950-BB85-CCD1F1A3BF67 Q36240984-5A229BF4-47E7-4357-BE5F-0D4B9BC31C9A Q36247866-D5D11D7A-D9D0-45C4-A3B6-027AFF2180C4 Q38142818-007C5B3E-7F32-4C24-836C-2A9DC894E110 Q38178187-FD3FD931-BA75-421A-B775-3E52BC1253D6 Q38195265-A19CB868-6EB9-49EF-8B74-772FED028671 Q38543780-1BF6E417-DE52-4C2E-8602-C81C407C40DC Q38994695-18FAD739-9820-415B-A663-9517921086E7 Q47093966-09424461-5154-47A0-895B-69C9B06C7C3E Q51493734-33E9ACA9-4DD5-4981-A647-A083C1E14D5C Q52903547-25AA7D0A-EA5F-46D6-B5CC-03B395BE852C Q55033406-DAFD788D-7353-4C40-A14B-0A4D56E20650

P2860

Ascertaining an appropriate diagnostic algorithm using EGFR mutation-specific antibodies to detect EGFR status in non-small-cell lung cancer.

http://www.wikidata.org/entity/Q34639632

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Ascertaining an appropriate di ...... in non-small-cell lung cancer.

@ast

Ascertaining an appropriate di ...... in non-small-cell lung cancer.

@en

Ascertaining an appropriate di ...... in non-small-cell lung cancer.

@nl

type

label

Ascertaining an appropriate di ...... in non-small-cell lung cancer.

@ast

Ascertaining an appropriate di ...... in non-small-cell lung cancer.

@en

Ascertaining an appropriate di ...... in non-small-cell lung cancer.

@nl

prefLabel

Ascertaining an appropriate di ...... in non-small-cell lung cancer.

@ast

Ascertaining an appropriate di ...... in non-small-cell lung cancer.

@en

Ascertaining an appropriate di ...... in non-small-cell lung cancer.

@nl

P1433

Q34639632-C65AA4C3-3C54-4438-A8DA-A836F440D029

P1476

Q34639632-88ED490B-CE6E-49C1-91FE-73C5DE476821

P2093

Q34639632-0BD4E180-A406-447F-80EA-CC3D1AB38627

Q34639632-2883FABC-FE6B-46DD-B392-51C3B70386D9

Q34639632-4802C6C5-48DB-4E8B-8255-F4D0E2963F68

Q34639632-6440C4A2-3937-4195-A8B7-44163CF681D8

Q34639632-8AB4CCD7-0141-49CC-81BE-4BE70F7A2B0E

Q34639632-8CFDB2DA-EBE7-42D0-B668-CCCEB9E4FE28

Q34639632-97157688-D5A9-4518-A480-D20291DD7107

Q34639632-B3B15AF9-1CE0-4DC5-959A-FD5DBD61E389

Q34639632-C70620C3-5D29-4048-AC13-2AA6384C95E0

Q34639632-CCF662F1-74C9-406B-A3AB-123E21533CA4

P2860

Q34639632-001A2212-8466-46FC-979E-EEC59BB690F0

Q34639632-087ACCA0-75CF-4198-8996-E4CC488206B4

Q34639632-09CB8187-0D63-42C1-BC94-826BD6255E47

Q34639632-0C30C6D0-897A-4569-AC8A-97E06C438729

Q34639632-242BAF2B-BD62-41C4-8216-2A2681DF147A

Q34639632-3F6F5384-171E-4A99-AC84-60E1DC258412

Q34639632-41933605-F638-4DD5-B4A3-65D5C19C1A7D

Q34639632-568F2B71-2F84-4618-B303-954C00D14B02

Q34639632-5CB1F985-D454-4CEA-AC10-5DDD84BA40F7

Q34639632-77E38555-7E8B-4F47-A0B6-C49B566783DC

P304

Q34639632-83D6E072-A08B-4821-8E9A-6EFB78278D58

P31

Q34639632-C8F30D8F-4DC0-4F7B-A6D0-155434B9F917

P356

Q34639632-312A82D3-8785-47D0-B5D2-BD38049E60D7

P407

Q34639632-F7F2A5B8-7734-4DDC-97E6-D68AE58B7868

P433

Q34639632-E3F4F716-0BF8-4BE9-906F-179BCB2CBADC

P478

Q34639632-BF7349BD-4651-4D92-B326-65D176A52F57

P577

Q34639632-10C8E75A-8A3B-4A13-BA09-533F663402BE

P5875

Q34639632-386C981E-16BA-453F-9B5C-DC6986DB3B81

P698

Q34639632-9B5CCE69-531B-4695-BDF2-41DFE14DC7CA

P921

Q34639632-A588610D-1DA7-497F-8CB5-E89785C003F9

P932

Q34639632-1615B4AD-CD9B-4BFF-AE64-A7DDD254CFB0

P356

JOURNAL.PONE.0059183

P1433

P1476

Ascertaining an appropriate di ...... in non-small-cell lung cancer.

@en

P2093

Chuifeng Fan

http://www.w3.org/2001/XMLSchema#string

Enhua Wang

http://www.w3.org/2001/XMLSchema#string

Guiyang Jiang

http://www.w3.org/2001/XMLSchema#string

Juanhan Yu

http://www.w3.org/2001/XMLSchema#string

Liang Wang

http://www.w3.org/2001/XMLSchema#string

Lianhe Yang

http://www.w3.org/2001/XMLSchema#string

Qianze Dong

http://www.w3.org/2001/XMLSchema#string

Shundong Dai

http://www.w3.org/2001/XMLSchema#string

Xiupeng Zhang

http://www.w3.org/2001/XMLSchema#string

Yang Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction

Novel epidermal growth factor receptor mutation-specific antibodies for non-small cell lung cancer: immunohistochemistry as a possible screening method for epidermal growth factor receptor mutations.

American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy.

Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence.

Update on epidermal growth factor receptor mutations in non-small cell lung cancer.

Standardization of epidermal growth factor receptor (EGFR) measurement by quantitative immunofluorescence and impact on antibody-based mutation detection in non-small cell lung cancer

P304

e59183

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0059183

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236088327

http://www.w3.org/2001/XMLSchema#string

P698

23536868

http://www.w3.org/2001/XMLSchema#string

P921

P932

3594188

http://www.w3.org/2001/XMLSchema#string